Observation on Edaravone and Alprostadil Injection in Treatment of 43 Cases Acute Cerebral Infarction
Wang Zheng-yu
Abstract
Wang Zheng-yu
Abstract
Objective: To explore the clinical efficacy of edaravone and alprostadil injection in treatment of patients with acute cerebral infarction(ACI).Method: 80 patients with the disease were randomly divided into observation group(43 cases) and control group(37 cases),patients in control group were treated with salvia miltiorrhiza injection and injection,while others were treared with edaravone and alprostadil injection.The treatment lasted for 14 days.Neurological deficit score(NDS),activities of daily living ability score(ADL) efficacy and complications were observed in all patients.Result: NDS and ADL improved significantly compared with before treatment in both groups(P0.05)..The total effective rate of the observation group was significantly higher than that of the control group,while the complication rate of the observation group was significantly lower than that of the control group(P0.05).Conclusion: The treatment of acute cerebral infarction with edaravone and alprostadil injection has a satisfy curative effect,and it is worth for clinical application.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To explore the clinical efficacy of edaravone and alprostadil injection in treatment of patients with acute cerebral infarction(ACI).Method: 80 patients with the disease were randomly divided into observation group(43 cases) and control group(37 cases),patients in control group were treated with salvia miltiorrhiza injection and injection,while others were treared with edaravone and alprostadil injection.The treatment lasted for 14 days.Neurological deficit score(NDS),activities of daily living ability score(ADL) efficacy and complications were observed in all patients.Result: NDS and ADL improved significantly compared with before treatment in both groups(P0.05)..The total effective rate of the observation group was significantly higher than that of the control group,while the complication rate of the observation group was significantly lower than that of the control group(P0.05).Conclusion: The treatment of acute cerebral infarction with edaravone and alprostadil injection has a satisfy curative effect,and it is worth for clinical application.
Key concepts: Medicine, Edaravone, Salvia miltiorrhiza, Clinical efficacy, Anesthesia, Cerebral infarction, Neurological deficit, Surgery